NDC 71558-590

Arikayce 590 mg per 8.4 mL suspension

On the label: Insmed Incorporated.

Italy: 1Canada: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Acs Dobfar SpaAlbano Sant'Alessandro (BG), ItalyMakes the active ingredient Problems found, fixed voluntarilySep 23, 2022 · 5 inspections
Resilience Biotechnologies, Inc.Mississauga, CanadaMakes it and tests it Problems found, fixed voluntarilyNov 10, 2023 · 2 inspections
Alcami Carolinas CorporationWilmington, NC, United StatesTests it Problems found, fixed voluntarilySep 26, 2025 · 11 inspections
Charles River Laboratories Ireland LimitedBallina, IrelandTests it Problems found, fixed voluntarilyMar 31, 2022 · 5 inspections
Fisher Clinical Services Inc.Allentown, PA, United StatesPackages it and labels it No problems foundMay 7, 2026 · 5 inspections
Labcorp Early Development Laboratories LimitedHarrogate, United KingdomTests it Problems found, fixed voluntarilyMar 9, 2022 · 8 inspections
PPD Development Ireland Ltd.Athlone, IrelandTests it Problems found, fixed voluntarilyMar 9, 2023 · 4 inspections
Sharp Packaging Services, LLCAllentown, PA, United StatesPackages it and labels it No problems foundNov 21, 2025 · 7 inspections
Wickham Micro LimitedGosport, United KingdomTests it Problems found, fixed voluntarilyFeb 2, 2023 · 5 inspections

Product details

Generic drug
Amikacin: every company that makes it
Form
suspension, respiratory (inhalation)
Strength
590 mg per 8.4 mL
Approval
NDA NDA207356
On the market since
Oct 12, 2018
Package NDCs
71558-590-28
Official label
DailyMed (National Library of Medicine), updated Aug 4, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?